Sindilizumab cannot be given if there is an infection in the lungs, it needs to be given after the infection is cured.
If there is an infection in the lungs, it is not recommended to take Sindilizumab directly, because in the adverse reactions of Sindilizumab, there is a lung infection, so if there is an infection in the lungs itself, the lung infection may be aggravated by Sindilizumab, and it is not possible to distinguish between the adverse reactions or the aggravation of one’s own condition.
Adverse reactions of Sindilizumab also include fever, anemia, liver function abnormalities, leukopenia, hyponatremia, upper gastrointestinal bleeding, etc. It is forbidden to use it for those who are allergic to components such as mannitol, histidine and sodium citrate.
To summarize, it is necessary to inoculate Sindilizumab after the lung infection is completely cured, in order to fully play the role of the drug, and at the same time, after the occurrence of adverse reactions can be clearly differentiated, so as to take targeted measures to deal with the problem.
The use of the drug should be in accordance with the doctor’s instructions, and it is recommended to consult the doctor to decide whether or not to be inoculated.